Bicycle Therapeutics

$29.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.52 (-1.74%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BCYC and other stocks, options, and ETFs commission-free!

About BCYC

Bicycle Therapeutics plc American Depositary Shares, also called Bicycle Therapeutics, is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles.

CEO
Kevin Lee
Employees
87
Headquarters
Cambridge, Cambridgeshire
Founded
2009
Market Cap
607.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
223.88K
High Today
$30.00
Low Today
$27.75
Open Price
$30.00
Volume
75.73K
52 Week High
$33.20
52 Week Low
$12.54

BCYC Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

RLGT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure